nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—White blood cell count increased—Metformin—polycystic ovary syndrome	0.0433	0.111	CcSEcCtD
Aprepitant—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0165	0.0423	CcSEcCtD
Aprepitant—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0155	0.0397	CcSEcCtD
Aprepitant—Hypothermia—Metformin—polycystic ovary syndrome	0.0155	0.0397	CcSEcCtD
Aprepitant—Upset stomach—Metformin—polycystic ovary syndrome	0.0133	0.034	CcSEcCtD
Aprepitant—Heartburn—Metformin—polycystic ovary syndrome	0.0126	0.0323	CcSEcCtD
Aprepitant—Rigors—Metformin—polycystic ovary syndrome	0.0106	0.0273	CcSEcCtD
Aprepitant—Chest discomfort—Metformin—polycystic ovary syndrome	0.00983	0.0252	CcSEcCtD
Aprepitant—CYP2C19—urine—polycystic ovary syndrome	0.00847	0.158	CbGeAlD
Aprepitant—CYP1A2—urine—polycystic ovary syndrome	0.00692	0.129	CbGeAlD
Aprepitant—Renal impairment—Metformin—polycystic ovary syndrome	0.00663	0.017	CcSEcCtD
Aprepitant—CYP2C9—urine—polycystic ovary syndrome	0.00657	0.122	CbGeAlD
Aprepitant—Lethargy—Metformin—polycystic ovary syndrome	0.00644	0.0165	CcSEcCtD
Aprepitant—Dehydration—Metformin—polycystic ovary syndrome	0.00587	0.015	CcSEcCtD
Aprepitant—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00576	0.0148	CcSEcCtD
Aprepitant—Breast disorder—Metformin—polycystic ovary syndrome	0.0057	0.0146	CcSEcCtD
Aprepitant—Cramp muscle—Metformin—polycystic ovary syndrome	0.00568	0.0145	CcSEcCtD
Aprepitant—Abdominal distension—Metformin—polycystic ovary syndrome	0.00549	0.0141	CcSEcCtD
Aprepitant—Sweating increased—Metformin—polycystic ovary syndrome	0.00531	0.0136	CcSEcCtD
Aprepitant—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00523	0.0134	CcSEcCtD
Aprepitant—Neutropenia—Metformin—polycystic ovary syndrome	0.0051	0.0131	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00507	0.013	CcSEcCtD
Aprepitant—CYP3A4—urine—polycystic ovary syndrome	0.00501	0.0934	CbGeAlD
Aprepitant—Infestation NOS—Metformin—polycystic ovary syndrome	0.00486	0.0125	CcSEcCtD
Aprepitant—Infestation—Metformin—polycystic ovary syndrome	0.00486	0.0125	CcSEcCtD
Aprepitant—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00477	0.0122	CcSEcCtD
Aprepitant—TACR1—adipose tissue—polycystic ovary syndrome	0.00473	0.0882	CbGeAlD
Aprepitant—Bradycardia—Metformin—polycystic ovary syndrome	0.00444	0.0114	CcSEcCtD
Aprepitant—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00434	0.0111	CcSEcCtD
Aprepitant—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00429	0.011	CcSEcCtD
Aprepitant—TACR1—adrenal gland—polycystic ovary syndrome	0.00424	0.0791	CbGeAlD
Aprepitant—Eye disorder—Metformin—polycystic ovary syndrome	0.00408	0.0104	CcSEcCtD
Aprepitant—Flushing—Metformin—polycystic ovary syndrome	0.00405	0.0104	CcSEcCtD
Aprepitant—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00405	0.0104	CcSEcCtD
Aprepitant—Angiopathy—Metformin—polycystic ovary syndrome	0.00396	0.0101	CcSEcCtD
Aprepitant—Immune system disorder—Metformin—polycystic ovary syndrome	0.00394	0.0101	CcSEcCtD
Aprepitant—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00394	0.0101	CcSEcCtD
Aprepitant—Chills—Metformin—polycystic ovary syndrome	0.00392	0.01	CcSEcCtD
Aprepitant—Erythema—Metformin—polycystic ovary syndrome	0.0038	0.00973	CcSEcCtD
Aprepitant—Malnutrition—Metformin—polycystic ovary syndrome	0.0038	0.00973	CcSEcCtD
Aprepitant—Flatulence—Metformin—polycystic ovary syndrome	0.00375	0.00959	CcSEcCtD
Aprepitant—Dysgeusia—Metformin—polycystic ovary syndrome	0.00372	0.00953	CcSEcCtD
Aprepitant—TACR1—endocrine gland—polycystic ovary syndrome	0.00368	0.0686	CbGeAlD
Aprepitant—Muscle spasms—Metformin—polycystic ovary syndrome	0.00365	0.00936	CcSEcCtD
Aprepitant—Tremor—Metformin—polycystic ovary syndrome	0.00356	0.00912	CcSEcCtD
Aprepitant—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00353	0.00903	CcSEcCtD
Aprepitant—Malaise—Metformin—polycystic ovary syndrome	0.00343	0.00877	CcSEcCtD
Aprepitant—Syncope—Metformin—polycystic ovary syndrome	0.00341	0.00873	CcSEcCtD
Aprepitant—Palpitations—Metformin—polycystic ovary syndrome	0.00336	0.0086	CcSEcCtD
Aprepitant—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00334	0.00855	CcSEcCtD
Aprepitant—Hypertension—Metformin—polycystic ovary syndrome	0.00328	0.0084	CcSEcCtD
Aprepitant—Chest pain—Metformin—polycystic ovary syndrome	0.00324	0.00828	CcSEcCtD
Aprepitant—Myalgia—Metformin—polycystic ovary syndrome	0.00324	0.00828	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00321	0.00823	CcSEcCtD
Aprepitant—Discomfort—Metformin—polycystic ovary syndrome	0.0032	0.00818	CcSEcCtD
Aprepitant—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00314	0.0586	CbGeAlD
Aprepitant—Oedema—Metformin—polycystic ovary syndrome	0.0031	0.00794	CcSEcCtD
Aprepitant—Infection—Metformin—polycystic ovary syndrome	0.00308	0.00789	CcSEcCtD
Aprepitant—Shock—Metformin—polycystic ovary syndrome	0.00305	0.00781	CcSEcCtD
Aprepitant—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00304	0.00779	CcSEcCtD
Aprepitant—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00304	0.00778	CcSEcCtD
Aprepitant—Skin disorder—Metformin—polycystic ovary syndrome	0.00301	0.00771	CcSEcCtD
Aprepitant—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.003	0.00768	CcSEcCtD
Aprepitant—Anorexia—Metformin—polycystic ovary syndrome	0.00296	0.00757	CcSEcCtD
Aprepitant—Hypotension—Metformin—polycystic ovary syndrome	0.0029	0.00742	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00283	0.00724	CcSEcCtD
Aprepitant—Paraesthesia—Metformin—polycystic ovary syndrome	0.00279	0.00713	CcSEcCtD
Aprepitant—Dyspnoea—Metformin—polycystic ovary syndrome	0.00277	0.00708	CcSEcCtD
Aprepitant—Somnolence—Metformin—polycystic ovary syndrome	0.00276	0.00706	CcSEcCtD
Aprepitant—Dyspepsia—Metformin—polycystic ovary syndrome	0.00273	0.00699	CcSEcCtD
Aprepitant—Decreased appetite—Metformin—polycystic ovary syndrome	0.0027	0.0069	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00268	0.00686	CcSEcCtD
Aprepitant—Fatigue—Metformin—polycystic ovary syndrome	0.00267	0.00685	CcSEcCtD
Aprepitant—Constipation—Metformin—polycystic ovary syndrome	0.00265	0.00679	CcSEcCtD
Aprepitant—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00256	0.00654	CcSEcCtD
Aprepitant—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00254	0.00649	CcSEcCtD
Aprepitant—Urticaria—Metformin—polycystic ovary syndrome	0.00246	0.00631	CcSEcCtD
Aprepitant—Abdominal pain—Metformin—polycystic ovary syndrome	0.00245	0.00628	CcSEcCtD
Aprepitant—Asthenia—Metformin—polycystic ovary syndrome	0.00223	0.0057	CcSEcCtD
Aprepitant—Pruritus—Metformin—polycystic ovary syndrome	0.00219	0.00562	CcSEcCtD
Aprepitant—Diarrhoea—Metformin—polycystic ovary syndrome	0.00212	0.00543	CcSEcCtD
Aprepitant—Dizziness—Metformin—polycystic ovary syndrome	0.00205	0.00525	CcSEcCtD
Aprepitant—Vomiting—Metformin—polycystic ovary syndrome	0.00197	0.00505	CcSEcCtD
Aprepitant—Rash—Metformin—polycystic ovary syndrome	0.00196	0.00501	CcSEcCtD
Aprepitant—Dermatitis—Metformin—polycystic ovary syndrome	0.00195	0.005	CcSEcCtD
Aprepitant—Headache—Metformin—polycystic ovary syndrome	0.00194	0.00497	CcSEcCtD
Aprepitant—Nausea—Metformin—polycystic ovary syndrome	0.00184	0.00472	CcSEcCtD
Aprepitant—CYP2C19—vagina—polycystic ovary syndrome	0.0015	0.028	CbGeAlD
Aprepitant—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00142	0.0265	CbGeAlD
Aprepitant—CYP2C19—endocrine gland—polycystic ovary syndrome	0.0014	0.0262	CbGeAlD
Aprepitant—CYP3A5—female gonad—polycystic ovary syndrome	0.00119	0.0222	CbGeAlD
Aprepitant—CYP3A5—vagina—polycystic ovary syndrome	0.00118	0.0221	CbGeAlD
Aprepitant—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00115	0.0214	CbGeAlD
Aprepitant—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00111	0.0206	CbGeAlD
Aprepitant—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00109	0.0203	CbGeAlD
Aprepitant—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00083	0.0155	CbGeAlD
Aprepitant—TACR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000178	0.000319	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000177	0.000319	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000177	0.000319	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000174	0.000314	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000174	0.000312	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000171	0.000307	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.00017	0.000306	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000168	0.000302	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000167	0.0003	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000166	0.000299	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000166	0.000298	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000166	0.000298	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000162	0.000292	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000162	0.000292	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000162	0.000291	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000159	0.000286	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000159	0.000286	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000158	0.000285	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000158	0.000284	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000157	0.000282	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000156	0.00028	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000154	0.000277	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000152	0.000273	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000152	0.000273	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000151	0.000272	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000148	0.000267	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000148	0.000266	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000148	0.000266	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000147	0.000265	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000147	0.000265	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000146	0.000262	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000145	0.000261	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000145	0.000261	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000145	0.000261	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000145	0.00026	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000144	0.00026	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000143	0.000257	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000142	0.000255	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000136	0.000245	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000135	0.000243	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000135	0.000243	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000135	0.000242	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000135	0.000242	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000134	0.000241	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000132	0.000237	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000132	0.000237	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000129	0.000232	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000129	0.000232	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000129	0.000232	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000128	0.00023	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000126	0.000227	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000126	0.000226	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000126	0.000226	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000125	0.000225	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000125	0.000224	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000124	0.000223	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000124	0.000223	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000123	0.000221	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000123	0.000221	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000122	0.00022	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000122	0.00022	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000121	0.000217	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000119	0.000214	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000119	0.000214	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000117	0.000211	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000117	0.00021	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000115	0.000207	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000115	0.000207	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000115	0.000206	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000114	0.000206	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000114	0.000206	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000112	0.000202	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000111	0.0002	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00011	0.000198	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.00011	0.000197	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000109	0.000196	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000108	0.000195	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000107	0.000193	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000105	0.000189	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000105	0.000189	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000105	0.000189	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000105	0.000188	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000104	0.000188	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—INS—polycystic ovary syndrome	0.000104	0.000188	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.000103	0.000186	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000102	0.000183	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000101	0.000182	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000101	0.000181	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	9.97e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	9.96e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	9.78e-05	0.000176	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	9.78e-05	0.000176	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	9.62e-05	0.000173	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	9.59e-05	0.000173	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.58e-05	0.000172	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.55e-05	0.000172	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.55e-05	0.000172	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	9.54e-05	0.000172	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	9.51e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	9.47e-05	0.00017	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.4e-05	0.000169	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.4e-05	0.000169	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—polycystic ovary syndrome	9.33e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	9.32e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.26e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.09e-05	0.000164	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	9.03e-05	0.000162	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.88e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.85e-05	0.000159	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	8.67e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.57e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	8.48e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	8.31e-05	0.00015	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	8.2e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TH—polycystic ovary syndrome	8.19e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	8.09e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	8.05e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.99e-05	0.000144	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	7.97e-05	0.000143	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	7.77e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	7.76e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	7.73e-05	0.000139	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.72e-05	0.000139	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.58e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.55e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.55e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	7.49e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	7.45e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	7.41e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	7.38e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.37e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	7.36e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.33e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.29e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	7.21e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	6.98e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	6.95e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.91e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	6.84e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	6.73e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	6.69e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	6.61e-05	0.000119	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.59e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	6.57e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	6.43e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	6.37e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.37e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.33e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	6.3e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.23e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	6.22e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	6.04e-05	0.000109	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	6e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.92e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.91e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.86e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	5.76e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.76e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	5.75e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.73e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.72e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	5.69e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.67e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.65e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	5.63e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.62e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.47e-05	9.84e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	5.44e-05	9.79e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	5.42e-05	9.75e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	5.37e-05	9.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	5.29e-05	9.52e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.25e-05	9.46e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.22e-05	9.4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.19e-05	9.34e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.15e-05	9.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.1e-05	9.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	5.01e-05	9.01e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.9e-05	8.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.86e-05	8.75e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	4.85e-05	8.72e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.83e-05	8.7e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.82e-05	8.68e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	4.67e-05	8.41e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.61e-05	8.29e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.58e-05	8.24e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	4.57e-05	8.22e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—polycystic ovary syndrome	4.56e-05	8.2e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	4.5e-05	8.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.49e-05	8.08e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—INS—polycystic ovary syndrome	4.48e-05	8.06e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.46e-05	8.03e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	4.45e-05	8.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.44e-05	7.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.43e-05	7.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.4e-05	7.92e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	4.37e-05	7.86e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.34e-05	7.8e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.2e-05	7.55e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.19e-05	7.54e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.19e-05	7.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.17e-05	7.51e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.12e-05	7.42e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	4.07e-05	7.32e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.06e-05	7.31e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.86e-05	6.95e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.82e-05	6.87e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.74e-05	6.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.74e-05	6.73e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.61e-05	6.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.57e-05	6.42e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.56e-05	6.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.47e-05	6.24e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.47e-05	6.24e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.42e-05	6.16e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.41e-05	6.13e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.38e-05	6.07e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.3e-05	5.94e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.26e-05	5.87e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.26e-05	5.86e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.25e-05	5.84e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.24e-05	5.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.23e-05	5.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.18e-05	5.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.15e-05	5.66e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.08e-05	5.54e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.91e-05	5.24e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.87e-05	5.16e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.77e-05	4.99e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.75e-05	4.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.68e-05	4.82e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.63e-05	4.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.55e-05	4.59e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.52e-05	4.53e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.52e-05	4.53e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.5e-05	4.5e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.45e-05	4.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.33e-05	4.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.29e-05	4.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.28e-05	4.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.25e-05	4.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.14e-05	3.85e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.03e-05	3.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.99e-05	3.58e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.96e-05	3.53e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.95e-05	3.51e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.89e-05	3.4e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.53e-05	2.76e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.51e-05	2.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.5e-05	2.71e-05	CbGpPWpGaD
